Personalized Immunomodulatory Therapy for HIV-related Cryptococcal Meningitis
Official title: Strategy Trial of Personalized Immunomodulatory Therapy for HIV-related Cryptococcal Meningitis
Funded at University of Minnesota · NIH-11615077 · Data updated 2026-11-12
A patient-focused study investigates a personalized treatment approach to improve outcomes for people with HIV who develop cryptococcal meningitis.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project start | September 21, 2026 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $314,988 |
| NIH project number | 3U01AI198071-01S1 |
| Project ID | NIH-11615077 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with HIV and cryptococcal meningitis who are receiving standard antifungal treatment.
✕Less likely to help
People without HIV-related cryptococcal meningitis or those not eligible for immunomodulatory approaches may not benefit.
What this research studies
This grant supports a strategy trial that aims to tailor immune-based therapy for adults living with HIV and cryptococcal meningitis. It builds on emerging ideas that the patient’s immune response, not just antifungal drugs, influences recovery. The study will investigate how to optimize immunomodulatory strategies alongside standard antifungal therapy to reduce death and complications. Participants may be adults with HIV who are receiving care in settings where cryptococcal meningitis is a major health concern.
Why it matters
Potential benefit: If successful, the approach could reduce mortality and improve recovery for HIV-related cryptococcal meningitis by personalizing immune support.
How similar studies have gone: Previous research suggests the host immune response contributes to outcomes, but personalized immunomodulation in this context is an emerging area with ongoing exploration.
Where this research is happening
-
University of Minnesota
Minneapolis, United States Active
Researchers
- Principal investigator: Boulware, David R — University of Minnesota
- Study coordinator: Boulware, David R
Related research
Other NIH-funded projects on the same topics.
-
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis
A study in Uganda aims to use faster, better tests and a new antifungal to help people with HIV who develop meningitis.
-
TB meningitis diagnostic test compare and cost study in sub-Saharan Africa
Researchers are testing a new CSF urine-based test (SILVAMP TB LAM) to improve diagnosis of TB meningitis in people with HIV, to help speed treatment and reduce death in Sub-Saharan Africa.
-
Minimally Invasive Sampling to Improve HIV-Associated M meningitis Diagnosis in Africa
A research study is testing easier, less invasive ways to diagnose meningitis in people living with HIV, with a focus on making diagnosis faster and more accurate in Africa and the US.
-
Understanding brain injury in kids with tuberculous meningitis (iThemba)
A study in children with TB meningitis in South Africa will look at how inflammation and blood-clotting factors relate to brain injury and infarcts.
-
Serological clues to survival in HIV-related cryptococcal meningitis
This grant looks for antibody signals in the blood that could predict who survives cryptococcal meningitis in people with HIV.
-
Blood-brain barrier problems during bacterial meningitis
Researchers are studying why the brain’s protective barrier fails during bacterial meningitis and how that leads to brain injury, with a focus on how bacteria invade brain cells and disrupt protective transporters.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.